Call for Late-breaking Abstracts
Don’t miss the chance for call for Late-breaking Abstracts submission!
Many clinical trials, including industry-initiated and investigator-initiated clinical trials, are being conducted in Japan and abroad. In some of these clinical trials, test results become available after the closure of abstract submission, while the results of others may be presented at international scientific meetings held immediately before the 111th Annual Meeting of JUA. Many urologists are surely keen to hear of such results.
We therefore have decided to have a Late-breaking & Encore Session during the 111th Annual Meeting to immediately share the latest findings with the association’s members.
We invite those wishing to share their latest research results at this session to submit abstracts.
Abstract Submission Period
February 1st(Thu.)-Noon,February 15th(Thu.),2024(JST)
Abstract Submission is now closed.
Thank you for your submission.
Important points in submitting late-breaking abstracts
- Only a limited number of late-breaking abstracts will be accepted.
- Whether abstracts are accepted or not and the presentation date will be determined by the scientific conference organizer and results will be notified to applicants late March.
- Late-breaking abstracts will not be included in the program book for the conference. They will only be posted on the online abstracts browsing system and the app. We would appreciate your understanding.
COI (Conflict of Interest) Disclosure Declaration
The first author of the presentation must disclose all necessary information in the provided COI form at the time of abstract submission.
Please include a COI disclosure slide below in your presentation.
Click here
Sample slide
Structure of Abstract
Abstract Category
| 1 | Adrenals | 12 | Neuro-urology |
|---|---|---|---|
| 2 | Upper tract benign disease | 13 | Incontinence |
| 3 | Kidney transplantation | 14 | Infertility |
| 4 | Renal tumors | 15 | Andrology |
| 5 | Urothelial tumors | 16 | Sexual dysfunction |
| 6 | Urinary reconstruction | 17 | Infectious disease |
| 7 | Prostate cancer | 18 | Stones |
| 8 | Testis tumors | 19 | Trauma and emergencies |
| 9 | Penile cancer | 20 | Pediatric urology |
| 10 | Male LUTS | 21 | Urethroplasty and genital reconstruction |
| 11 | Female LUTS | 22 | Others |
Abstracts must be submitted in English, not exceeding 1600 characters.
The material for presentation should be unpublished and original.
Inquries for Abstract Submission
Congress Secretariat
c/o Japan Convention Services, Inc.
E-mail: endai-jua2024@convention.co.jp